1064. Clinical Outcomes of Daptomycin in Combination With Ceftaroline or Anti-Staphylococcal Penicillins for Patients With Persistent MRSA Bacteremia

BACKGROUND: Daptomycin-β-lactam (DAP-BL) combinations demonstrate in vitro synergy against MRSA; however, the clinical efficacy of combo is limited. Our objective was to compare the outcomes of patients with persistent MRSA bacteremia treated with DAP-BL combinations. METHODS: Retrospective, cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchard, Jeannette, Oleksiuk, Louise-Marie, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254512/
http://dx.doi.org/10.1093/ofid/ofy210.901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254512/
http://dx.doi.org/10.1093/ofid/ofy210.901

Ejemplares similares